Clinical Trials Browser

Phase 1 × Lymphoma × CUDC-907 × Clear all

NCT02909777 2026-02-11

Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma

Phase 1 Completed

Brain Neoplasms, Lymphoma, Neuroblastoma

NCT01742988 2021-05-06

Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma

Phase 1 Completed

Lymphoma, Lymphoma, Large B-Cell, Diffuse